New treatment for drug-resistant tuberculosis commences in Papua New Guinea
Evelyn Lavu Travel Scholarship
Burnet welcomes Dr Andrew Nash to its Board of Directors
Providing support to the people of Myanmar
Research Reports + Policy Briefs
IMPACT Magazine
Events
Research Articles
How Science Matters Podcast
Study at Burnet
"Quick, simple, and friendly": Understanding the acceptability and accessibility...
Antimicrobials for Neonates: Practitioner Decisions and Diagnostic Certainty.
Factors Associated with Timely First-Dose Pentavalent and Measles-Rubella Vaccin...
Agency in young people’s unsafe abortion trajectories in Papua New Guinea.
Vaccines
Diagnostics
Therapeutics
Antibody Platforms
Australia
Papua New Guinea
Myanmar
People of Burnet
Leadership
Burnet Partners
Board Members
Appeals
Monthly Giving
Trusts + Foundations
Corporate Supporters
Giving in Wills + Bequests
Supporter Stories
About Us
Careers
History
Annual + Financial Reports
Burnet is committed to strengthening health systems in collaboration with Government and non-Governm...
Burnet’s epidemiological studies help inform policy and practice, and provide evidence-based recomme...
Burnet is at the forefront of using data and modelling across areas including COVID-19, hepatitis C ...
We perform discovery research in the areas of life sciences, biomedicine, qualitative and quantitati...
Burnet works in partnership with people and affected communities to bring about sustainable change. ...
Burnet Institute develops, tests, and evaluates new tools, interventions, and programs to address pu...